| 作者 |
[还债帖 ]制药业的走向 |
 |
| 所跟贴 |
[还债帖 ]制药业的走向 -- theoretical - (613 Byte) 2008-11-11 周二, 12:38 (3502 reads) |
Hooya
头衔: 海归中士 声望: 学员
加入时间: 2008/04/30 文章: 68
海归分: 855
|
|
作者:Hooya 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
and now moving some of the R&D to China are because their cancer drugs in China are extremely profitable--profit margin over 95%! Besides, China has far less regulation than US.
Layoffs after 3-5 years of M&A are quite normal, and companies usually have layoffs in the same times, so that their key employees have less chance to hop to other companies.
Big Pharma are far more stable than most others, though they may lose the good old times of having half day lunch! 
作者:Hooya 在 海归商务 发贴, 来自【海归网】 http://www.haiguinet.com
|
|
|
| 返回顶端 |
|
 |
|
-
[还债帖 ]制药业的走向 -- theoretical - (613 Byte) 2008-11-11 周二, 12:38 (3502 reads) - A couple of big Pharma having productions in China, -- Hooya - (491 Byte) 2008-11-12 周三, 14:21 (440 reads)
|
|
|
|
您不能在本论坛发表新主题, 不能回复主题, 不能编辑自己的文章, 不能删除自己的文章, 不能发表投票, 您 不可以 发表活动帖子在本论坛, 不能添加附件不能下载文件, |
|
|